rs2302566

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016955.4(SEPSECS):​c.1356G>C​(p.Lys452Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0541 in 1,613,602 control chromosomes in the GnomAD database, including 2,992 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 585 hom., cov: 32)
Exomes 𝑓: 0.052 ( 2407 hom. )

Consequence

SEPSECS
NM_016955.4 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.06

Publications

16 publications found
Variant links:
Genes affected
SEPSECS (HGNC:30605): (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) The amino acid selenocysteine is the only amino acid that does not have its own tRNA synthetase. Instead, this amino acid is synthesized on its cognate tRNA in a three step process. The protein encoded by this gene catalyzes the third step in the process, the conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).[provided by RefSeq, Mar 2011]
SEPSECS Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2D
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Broad Center for Mendelian Genomics, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive cerebello-cerebral atrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_016955.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024281442).
BP6
Variant 4-25124081-C-G is Benign according to our data. Variant chr4-25124081-C-G is described in ClinVar as Benign. ClinVar VariationId is 130288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016955.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEPSECS
NM_016955.4
MANE Select
c.1356G>Cp.Lys452Asn
missense
Exon 11 of 11NP_058651.3Q9HD40-1
SEPSECS
NM_001410714.1
c.1611G>Cp.Lys537Asn
missense
Exon 12 of 12NP_001397643.1A0A7P0TA23

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEPSECS
ENST00000382103.7
TSL:1 MANE Select
c.1356G>Cp.Lys452Asn
missense
Exon 11 of 11ENSP00000371535.2Q9HD40-1
SEPSECS
ENST00000358971.7
TSL:1
n.*1154G>C
non_coding_transcript_exon
Exon 12 of 12ENSP00000351857.3J3KP25
SEPSECS
ENST00000514585.5
TSL:1
n.*1057G>C
non_coding_transcript_exon
Exon 10 of 10ENSP00000421880.1Q9HD40-2

Frequencies

GnomAD3 genomes
AF:
0.0775
AC:
11784
AN:
151990
Hom.:
580
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0684
Gnomad ASJ
AF:
0.0285
Gnomad EAS
AF:
0.111
Gnomad SAS
AF:
0.0913
Gnomad FIN
AF:
0.0458
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0451
Gnomad OTH
AF:
0.0722
GnomAD2 exomes
AF:
0.0662
AC:
16629
AN:
251056
AF XY:
0.0645
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.0727
Gnomad ASJ exome
AF:
0.0349
Gnomad EAS exome
AF:
0.126
Gnomad FIN exome
AF:
0.0499
Gnomad NFE exome
AF:
0.0455
Gnomad OTH exome
AF:
0.0655
GnomAD4 exome
AF:
0.0516
AC:
75429
AN:
1461494
Hom.:
2407
Cov.:
32
AF XY:
0.0521
AC XY:
37911
AN XY:
727054
show subpopulations
African (AFR)
AF:
0.142
AC:
4742
AN:
33466
American (AMR)
AF:
0.0720
AC:
3220
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0342
AC:
892
AN:
26120
East Asian (EAS)
AF:
0.124
AC:
4914
AN:
39680
South Asian (SAS)
AF:
0.0798
AC:
6879
AN:
86246
European-Finnish (FIN)
AF:
0.0474
AC:
2534
AN:
53408
Middle Eastern (MID)
AF:
0.0553
AC:
319
AN:
5768
European-Non Finnish (NFE)
AF:
0.0437
AC:
48559
AN:
1111718
Other (OTH)
AF:
0.0558
AC:
3370
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3776
7551
11327
15102
18878
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1924
3848
5772
7696
9620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0776
AC:
11798
AN:
152108
Hom.:
585
Cov.:
32
AF XY:
0.0769
AC XY:
5720
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.141
AC:
5843
AN:
41462
American (AMR)
AF:
0.0682
AC:
1041
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0285
AC:
99
AN:
3470
East Asian (EAS)
AF:
0.111
AC:
573
AN:
5176
South Asian (SAS)
AF:
0.0908
AC:
438
AN:
4826
European-Finnish (FIN)
AF:
0.0458
AC:
486
AN:
10602
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0451
AC:
3066
AN:
67980
Other (OTH)
AF:
0.0776
AC:
164
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
552
1104
1657
2209
2761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0537
Hom.:
196
Bravo
AF:
0.0834
Asia WGS
AF:
0.121
AC:
423
AN:
3478
EpiCase
AF:
0.0475
EpiControl
AF:
0.0503

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Pontocerebellar hypoplasia type 2D (3)
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T
Eigen
Benign
0.11
Eigen_PC
Benign
0.050
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
1.1
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.41
Sift
Benign
0.18
T
Sift4G
Benign
0.27
T
Varity_R
0.41
gMVP
0.39
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2302566;
hg19: chr4-25125703;
COSMIC: COSV57206810;
COSMIC: COSV57206810;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.